MS
INBX

Maven Securities’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Maven Securities’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,800
Closed -$439K – 1465
2021
Q2 		$439K Buy
+15,800
New +$329K 0.02% 712
2020
Q4 		– Sell
-10,421
Closed -$185K – 972
2020
Q3 		$185K Buy
+10,421
New +$189K 0.02% 564

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Maven Securities's INBX Position: Q3 2021 in Review

Maven Securities sold out of Inhibrx, Inc. Common Stock (INBX) in Q3 2021, closing a stake of 15,800 shares — an estimated $439K sold.

Maven Securities first reported a position in INBX in Q3 2020 and held it in 2 quarters. The position peaked at $439K in Q2 2021. 66 funds tracked by Wall St. Rank hold INBX as of Q3 2021.

  • Maven Securities reported no remaining Inhibrx, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Maven Securities sold 15,800 Inhibrx, Inc. Common Stock shares in Q3 2021, an estimated $439K.
  • Maven Securities first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Maven Securities's Inhibrx, Inc. Common Stock position peaked at $439K in Q2 2021.
  • 66 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q3 2021.

Based on Maven Securities's 13F filing for Q3 2021, filed 15 Nov 2021.